Journal
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
Volume 32, Issue 4, Pages 205-210Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/03009740310003686
Keywords
homocysteine; rheumatoid arthritis; cardiovascular disease; inflammation; methotrexate; vitamin B12; vitamin B6; folic acid
Categories
Ask authors/readers for more resources
Objectives: To investigate the effects of treatment with B vitamins on homocysteine (Hcy) levels in patients with RA, and to analyse the relationship between Hcy levels and inflammatory variables, and/or MTX treatment. Methods: Sixty-two patients with RA and levels of Hcy greater than or equal to 12 mmol/L were randomized to receive placebo or a combination of vitamins B6, B12 and folic acid. The patients were treated and evaluated in a double-blind manner over 12 months. Results: The Hcy level decreased significantly in the B-vitamin treated patients compared with the placebo treated patients. In a simple regression model, the Hcy level at inclusion was associated with IL-2sRalpha. In a multiple regression model there was an association between the alteration in Hcy level over 0-12 months and MTX treatment, as well as the alteration in CRP, adjusted for B-vitamin treatment. Conclusions: In patients with RA, Hcy levels can be reduced by treatment with B-vitamins. The Hcy levels were related to markers of inflammation and MTX treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available